Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues

BACKGROUND: Topoisomerase I (Top1) is a proven target for cancer therapeutics. Recent data from the Fluorouracil, Oxaliplatin, CPT-11: Use and Sequencing (FOCUS) trial demonstrated that nuclear staining of Top1 correlates with chemotherapeutic efficacy. Such a correlation may help identify patients...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Pfister, Thomas D., Hollingshead, Melinda, Kinders, Robert J., Zhang, Yiping, Evrard, Yvonne A., Ji, Jiuping, Khin, Sonny A., Borgel, Suzanne, Stotler, Howard, Carter, John, Divelbiss, Raymond, Kummar, Shivaani, Pommier, Yves, Parchment, Ralph E., Tomaszewski, Joseph E., Doroshow, James H.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2012
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3532478/
https://ncbi.nlm.nih.gov/pubmed/23284638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0050494
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki